Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AZN | AMGN | GILD | VRTX |
| Company | Biomarin Pharmaceuticals | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 58.80 | 92.25 | 328.69 | 123.24 | 451.75 |
| High | 59.72 | 92.48 | 329.50 | 123.60 | 455.92 |
| Low | 58.44 | 91.92 | 327.06 | 122.38 | 451.75 |
| Latest | 59.43 | 91.93 | 327.31 | 122.74 | 453.36 |
| Change | +0.44 | -0.58 | -1.38 | -0.44 | -0.38 |
| % Change | +0.75% | -0.63% | -0.42% | -0.36% | -0.08% |
| Volume | 1,398,700 | 2,097,300 | 1,417,200 | 3,149,200 | 692,900 |
| 20-Day Average Volume | 2,996,360 | 4,869,490 | 2,971,045 | 6,762,850 | 1,311,035 |
| Previous Close | 58.99 | 92.51 | 328.69 | 123.18 | 453.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 55.82 | 91.23 | 327.32 | 122.53 | 453.68 |
| 20-Day Raw Stochastic | 65.67% | 69.37% | 43.90% | 49.46% | 63.83% |
| 20-Day Relative Strength | 59.74 | 57.60 | 51.99 | 50.34 | 55.92 |
| Weighted Alpha | -6.69 | +40.98 | +24.53 | +30.31 | +11.10 |
| Today's Opinion | 24% Buy | 100% Buy | 80% Buy | 64% Buy | 56% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.80% since 12/23/25 | -0.23% since 12/23/25 | -1.26% since 12/23/25 | -1.96% since 12/23/25 | -1.27% since 12/23/25 |
| Low | 58.44 on 12/31/25 | 91.92 on 12/31/25 | 325.83 on 12/30/25 | 122.38 on 12/31/25 | 451.75 on 12/31/25 |
| High | 61.24 on 12/24/25 | 92.91 on 12/26/25 | 334.38 on 12/24/25 | 126.25 on 12/24/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | +6.26% since 11/28/25 | -0.85% since 11/28/25 | -5.25% since 11/28/25 | -2.46% since 11/28/25 | +4.55% since 11/28/25 |
| Low | 50.90 on 12/15/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 63.89 on 12/19/25 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +9.73% since 09/30/25 | +19.83% since 09/30/25 | +15.99% since 09/30/25 | +10.58% since 09/30/25 | +15.76% since 09/30/25 |
| Low | 50.76 on 11/07/25 | 80.48 on 11/04/25 | 283.00 on 10/01/25 | 108.46 on 10/02/25 | 392.49 on 10/01/25 |
| High | 63.89 on 12/19/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | +8.11% since 06/30/25 | +31.55% since 06/30/25 | +17.23% since 06/30/25 | +10.71% since 06/30/25 | +1.83% since 06/30/25 |
| Low | 50.76 on 11/07/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 63.97 on 08/05/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,332,804 | 286,915,328 | 176,993,312 | 152,826,976 | 115,122,448 |
| Shares Outstanding, K | 192,114 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 2,853,920,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 426,860,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 776,130,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -30,740,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.30 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.12 on 10/27/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/18/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 20.92 | 20.25 | 15.07 | 15.25 | 30.03 |